Adolescent Vaccination Kiosk Project

This study has been completed.
Sponsor:
Collaborator:
Society for Adolescent Health & Medicine
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01622608
First received: June 15, 2012
Last updated: December 20, 2013
Last verified: December 2013
  Purpose

The purpose of this study is to determine whether implementation of a web-based educational intervention using a "vaccine information kiosk" placed in primary care practice waiting rooms can reach a large number of parents and have a measurable impact on adolescent vaccination rates, specifically for Tdap, HPV, meningococcal, and influenza vaccines.


Condition Intervention
Adolescent Vaccination Status
Behavioral: Vaccine Information Kiosk

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Adolescent Vaccination Kiosk Project

Further study details as provided by University of Colorado, Denver:

Primary Outcome Measures:
  • Utilization of vaccine information kiosks by parents/patients. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Descriptive statistics on kiosk utilization patterns overall, and disaggregated by various demographic, attitudinal and vaccination status categories will be derived. This will be assessed in intervention settings using data entered by parents, as well as paradata such as the order of web pages viewed, and time spent per page.

  • Usefulness of vaccine information kiosks [ Time Frame: 12 months (provider survey) & 3 months (parent survey) ] [ Designated as safety issue: No ]
    Parent satisfaction with the material presented in the kiosk, as well as changes between parents' baseline survey (done at the kiosk) and follow-up email survey in: 1) parent attitudes about vaccination and 2) parent vaccine-specific vaccination intention will be assessed. Provider views on having the kiosks in the waiting room of their clinic will also be assessed.

  • Proportion of adolescents who had a change in their vaccination status in kiosk users compared to non-users. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Vaccination status will be determined primarily by medical record review, and augmented by parent report. The proportion of adolescents who had a change in their vaccination status (Tdap, MCV, HPV, Flu) before versus after their clinic visit (for non-users of the kiosk), or before versus after the date their parent first accessed the intervention (for users of the kiosk) will be assessed.


Enrollment: 42
Study Start Date: August 2012
Study Completion Date: September 2013
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Kiosk Users Behavioral: Vaccine Information Kiosk
The study kiosk will remain in the waiting room of participating practices for the duration of the study. Interested parents will self-direct to the kiosk in the clinic waiting room either before or after their child's appointment. Following consent, parents will complete a survey that assesses socio-demographics, baseline vaccination intention, and vaccine-specific beliefs, attitudes and experiences. The kiosk will generate tailored educational messages about adolescent vaccines. Parents can utilize the kiosk as many times as they wish during the intervention period.
No Intervention: Non-Kiosk Users

Detailed Description:

Adolescents are a reservoir population for a variety of vaccine preventable diseases (VPDs). Despite this, adolescent vaccination rates lag substantially behind national goals of 80% coverage for adolescent vaccines set forth by Healthy People 2020. This has been particularly the case for the vaccines most recently recommended for adolescents, such as the human papillomavirus (HPV) and seasonal influenza (flu) vaccines; national coverage levels in 2010 for HPV were 32% (for series completion among females only) and 35% for flu vaccine. Uptake levels for the two other adolescent-targeted vaccines, tetanus-diphtheria-acellular pertussis (Tdap) and meningococcal conjugate (MCV4) vaccines are currently at 69% and 63%, respectively.

A major barrier to increased adolescent vaccination levels is the lack of parental and provider recognition that an adolescent is due for vaccine doses. For providers, there are the dual challenges of getting adolescents to come in for annual preventive care visits and also minimizing "missed opportunities" for vaccination (i.e. clinical interactions with a patient where a needed vaccine could have been provided but was not). Reminder/recall systems are one mechanism to help address both of these challenges for providers while also informing parents about the need for adolescent vaccines.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Parents of adolescents (11-17 years) attending one of 3 participating pediatric practices.
  • able to read and converse in English.

Exclusion Criteria:

  • Parent age < 18 years,
  • prisoners,
  • decisionally challenged participants.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01622608

Locations
United States, Colorado
Pediatrics 5280
Centennial, Colorado, United States, 80112
Mountainland Pediatrics
Thornton, Colorado, United States, 80260
Pediatrics West
Wheat Ridge, Colorado, United States, 80033
Sponsors and Collaborators
University of Colorado, Denver
Society for Adolescent Health & Medicine
Investigators
Principal Investigator: Amanda Dempsey, MD, PhD, MPH University of colorado, Children's Hospital Colorado
Principal Investigator: Sean O'Leary, MD, MPH University of Colorado Denver, Children's Hospital Colorado
Principal Investigator: Lawrence An, MD University of Michigan, Masonic Cancer Center
  More Information

No publications provided

Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT01622608     History of Changes
Other Study ID Numbers: 12-0179
Study First Received: June 15, 2012
Last Updated: December 20, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Colorado, Denver:
Adolescent vaccination
Immunization rates
Informational kiosk
Tailored health messaging
Barriers to vaccination
Attitudes
Intentions

ClinicalTrials.gov processed this record on August 28, 2014